Beyond Air’s (XAIR) “Buy” Rating Reaffirmed at D. Boral Capital

D. Boral Capital reiterated their buy rating on shares of Beyond Air (NASDAQ:XAIR) in a report issued on Tuesday,Benzinga reports. They currently have a $10.00 price target on the stock.

Several other research analysts have also issued reports on the stock. Rodman & Renshaw started coverage on shares of Beyond Air in a research note on Tuesday, January 20th. They issued a “buy” rating for the company. Wall Street Zen upgraded shares of Beyond Air to a “sell” rating in a report on Saturday. Finally, Weiss Ratings reaffirmed a “sell (e)” rating on shares of Beyond Air in a research note on Monday, December 22nd. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average price target of $10.00.

Beyond Air Stock Performance

Shares of XAIR opened at $0.82 on Tuesday. Beyond Air has a one year low of $0.67 and a one year high of $6.44. The company has a 50-day simple moving average of $1.15 and a two-hundred day simple moving average of $1.60. The company has a debt-to-equity ratio of 2.65, a current ratio of 5.12 and a quick ratio of 4.77. The firm has a market capitalization of $8.68 million, a PE ratio of -0.15 and a beta of 0.41.

Beyond Air (NASDAQ:XAIR) last released its quarterly earnings results on Friday, February 13th. The company reported ($0.85) earnings per share for the quarter, missing the consensus estimate of ($0.54) by ($0.31). The firm had revenue of $2.19 million for the quarter, compared to the consensus estimate of $2.15 million. Beyond Air had a negative net margin of 447.75% and a negative return on equity of 268.82%. On average, analysts anticipate that Beyond Air will post -0.79 EPS for the current fiscal year.

Institutional Trading of Beyond Air

Several institutional investors have recently made changes to their positions in the business. Geode Capital Management LLC raised its position in Beyond Air by 57.5% during the fourth quarter. Geode Capital Management LLC now owns 67,678 shares of the company’s stock valued at $49,000 after purchasing an additional 24,695 shares during the period. Alyeska Investment Group L.P. bought a new position in shares of Beyond Air in the third quarter worth about $1,753,000. Virtu Financial LLC bought a new position in Beyond Air in the 3rd quarter worth about $48,000. Osaic Holdings Inc. increased its holdings in Beyond Air by 26.4% during the 2nd quarter. Osaic Holdings Inc. now owns 162,560 shares of the company’s stock worth $29,000 after purchasing an additional 34,000 shares during the period. Finally, Alpine Global Management LLC bought a new stake in shares of Beyond Air in the third quarter valued at about $25,000. Hedge funds and other institutional investors own 31.50% of the company’s stock.

Beyond Air Company Profile

Beyond Air, Inc is a clinical-stage medical technology company focused on the development and commercialization of inhaled nitric oxide (NO) therapy for pulmonary and respiratory diseases. The company’s proprietary LungFit® platform delivers pulsed, low-dose nitric oxide gas through compact, portable devices designed to support treatments in both inpatient and outpatient settings. Beyond Air’s approach leverages NO’s antimicrobial, vasodilatory and anti-inflammatory properties to address a range of unmet needs in respiratory medicine.

The company’s lead candidate, LungFit® PH, is under investigation for the treatment of pulmonary hypertension, with ongoing clinical studies assessing its impact on pulmonary arterial pressure and exercise capacity.